IRIS
TISONE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 82.525
AS - Asia 11.380
EU - Europa 7.655
SA - Sud America 1.540
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 17
Totale 103.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 82.219
SG - Singapore 5.551
CN - Cina 2.220
RU - Federazione Russa 1.276
BR - Brasile 1.262
HK - Hong Kong 1.259
IT - Italia 1.076
UA - Ucraina 1.073
DE - Germania 1.048
VN - Vietnam 822
IE - Irlanda 816
FI - Finlandia 661
GB - Regno Unito 462
SE - Svezia 362
FR - Francia 335
KR - Corea 296
JP - Giappone 288
BD - Bangladesh 261
IN - India 197
CA - Canada 172
NL - Olanda 127
AR - Argentina 108
PL - Polonia 96
TR - Turchia 78
AT - Austria 75
ID - Indonesia 72
MX - Messico 71
ES - Italia 62
IQ - Iraq 57
ZA - Sudafrica 47
EC - Ecuador 44
BE - Belgio 36
CO - Colombia 32
CL - Cile 29
CZ - Repubblica Ceca 29
SA - Arabia Saudita 23
EG - Egitto 22
PK - Pakistan 20
PY - Paraguay 20
UZ - Uzbekistan 20
CH - Svizzera 18
MY - Malesia 17
AE - Emirati Arabi Uniti 16
AU - Australia 16
IL - Israele 15
PH - Filippine 15
AZ - Azerbaigian 14
JM - Giamaica 14
JO - Giordania 14
KE - Kenya 14
RO - Romania 14
TH - Thailandia 14
VE - Venezuela 14
EU - Europa 13
GR - Grecia 13
MA - Marocco 13
NP - Nepal 13
TN - Tunisia 13
KG - Kirghizistan 12
UY - Uruguay 12
DZ - Algeria 11
IR - Iran 11
KZ - Kazakistan 11
PE - Perù 11
LT - Lituania 10
MD - Moldavia 10
DO - Repubblica Dominicana 9
TT - Trinidad e Tobago 9
HN - Honduras 7
OM - Oman 7
BO - Bolivia 6
LB - Libano 6
NO - Norvegia 6
BG - Bulgaria 5
NG - Nigeria 5
PT - Portogallo 5
SN - Senegal 5
TW - Taiwan 5
AL - Albania 4
AM - Armenia 4
CR - Costa Rica 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
KH - Cambogia 4
KW - Kuwait 4
LV - Lettonia 4
MN - Mongolia 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TM - Turkmenistan 4
A1 - Anonimo 3
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
DK - Danimarca 3
DM - Dominica 3
LK - Sri Lanka 3
MK - Macedonia 3
MM - Myanmar 3
NI - Nicaragua 3
Totale 103.226
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.646
Wilmington 21.024
Houston 18.730
Singapore 2.741
Fairfield 2.215
Ann Arbor 1.942
Ashburn 1.502
Hong Kong 1.236
San Jose 1.205
Chandler 1.162
Jacksonville 969
Seattle 953
Cambridge 825
Beijing 821
New York 821
Dublin 801
Medford 599
Santa Clara 482
Helsinki 409
The Dalles 393
Dearborn 330
Los Angeles 329
Rome 326
Council Bluffs 305
Zhengzhou 283
Lawrence 281
Ho Chi Minh City 259
Tokyo 231
Moscow 220
Buffalo 213
Hanoi 182
Mülheim 172
San Diego 148
São Paulo 139
Lauterbourg 126
Dallas 105
Milan 103
Orem 102
Menlo Park 95
Elk Grove Village 93
Chicago 91
Hangzhou 87
Munich 75
London 71
Shanghai 67
Frankfurt am Main 65
Atlanta 63
Chennai 63
Montreal 59
Jersey City 58
Nuremberg 58
Phoenix 54
San Mateo 54
Creede 51
North Bergen 51
Redwood City 50
Guangzhou 49
University Park 49
Warsaw 49
Manchester 46
Palo Alto 46
Mountain View 44
Amsterdam 43
Rio de Janeiro 43
Boardman 41
Jakarta 41
Nanjing 41
Denver 40
Verona 40
Falls Church 39
Saint Petersburg 39
Brooklyn 38
Johannesburg 38
Norwalk 38
Stockholm 37
Redondo Beach 36
Columbus 34
Poplar 34
San Francisco 34
Toronto 34
Hefei 33
Vienna 33
Da Nang 30
Kraków 30
Seoul 30
Brussels 28
Lappeenranta 28
Engelhard 27
Belo Horizonte 26
Haiphong 26
Salt Lake City 26
Mexico City 25
Kunming 24
Mumbai 24
Turku 23
Brasília 22
Curitiba 21
Turin 21
Ankara 20
Miami 20
Totale 88.025
Salva come PNG Salva come JPEG
Nome #
Hepatitis C reinfection after liver transplantation in relation to virus genotype 611
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression 581
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 554
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 529
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 527
Recurrence of insulin resistant metabolic syndrome following liver transplantation 508
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 506
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 506
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 505
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 504
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 502
Graft failure due to hemolytic uremic syndrome recurrence 499
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 499
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 497
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 492
Operational tolerance in clinical liver transplantation: emerging developments. 490
Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. 488
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 488
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 485
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft 484
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 483
Use of mycophenolate mofetil in liver transplantation: a literature review. 483
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 482
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. 481
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 476
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 476
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 475
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 472
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 471
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 471
Marginal donors in liver transplantation. 470
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 469
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 466
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 466
Infectious complications in renal transplant recipients 464
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 462
596 460
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 459
Is nephrectomy indicated in uremic patients with ADPKD waiting for transplant? 459
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 458
Leptin attenuates ischemia-reperfusion injury in the rat liver. 457
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. 456
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 454
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 453
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 451
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 451
Clinical and neurophysiological evidence of polyneuropathy in liver transplant candidates: preliminary report. 450
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 449
10-28 year follow-up in 23 patients with kideny traansplantation: immunosuppressive therapy, survival and complications 448
Management of spermatic cord liposarcoma in renal transplant recipients: case report 447
Liver abscess caused by foreign body ingestion 447
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 446
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 445
Multiparameter immune profiling of operational tolerance in liver transplantation. 444
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 444
Flow cytometric analysis of antidonor-specific antibodies in liver transplant. 443
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: With or without steroids? 443
Graft failure due to hemolytic uremic syndrome recurrence 442
Phase I clinical trial with the AMC-bioartificial liver. 441
Quality of life and long-term follow-up after kidney transplantation: a 30-year clinical study. 441
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 440
Ureteral obstruction in 140 renal transplant patients: preventions and treatment 440
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 439
Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. 438
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 437
Immunosuppression-Free Liver Transplantation 437
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 437
Reduced acute rejection and side effects with neoral in liver transplantation. 437
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 436
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 435
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 434
Sequential changes in serum and biliary bile acids after liver transplantation 433
Liver transplantation for end-stage liver disease related to viral hepatitis 433
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 432
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 431
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 430
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 430
Split-liver transplantation with pediatric donors: a multicenter experience. 429
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 429
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 428
Clinical Significance of de novo production of HLA of donor-specific antibodies in kidney transplantation. 428
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. 428
Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. 428
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 428
Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: a prospective randomized study. 427
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 427
Average results and follow-up in 11 over-60 years of age kidney transplanted patients 427
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 427
Spontaneous resolution of severe acute rejection in liver transplantation. 425
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. 425
[An unusual case of ureteral obstruction after kidney transplantation]. 425
Characterization of γδ T cell subsets in organ transplantation. 424
Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study 424
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 423
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation 422
Liver transplantation for the treatment of nodular regenerative hyperplasia 422
Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. 421
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 421
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 421
Totale 45.945
Salva come PNG Salva come JPEG
Categoria #
all - tutte 250.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 250.613
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.815 104 300 92 159 78 324 133 118 270 311 123 803
2022/20233.515 373 285 80 362 272 799 322 323 295 23 291 90
2023/20241.299 145 41 187 25 137 306 52 40 31 65 23 247
2024/20258.341 254 1.658 822 477 138 572 593 305 753 713 1.167 889
2025/202613.697 1.032 692 1.339 1.344 1.231 829 1.768 1.799 1.443 1.087 655 478
2026/202792 92 0 0 0 0 0 0 0 0 0 0 0
Totale 104.210